News | News By Subject | News by Disease News By Date | Search News

Glioblastoma/Glioma News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Fortress Biotech (FBIO) Surged After Reporting Big Success With CAR-T Cancer Approach     12/30/2016
Glioblastoma Treatment Market Will Expand to $3.3 Billion by 2024, GlobalData Report Says     1/14/2016
Agenus (AGEN) Acquires PhosImmune in $44.9 Million Deal     12/29/2015
Celldex (CLDX) Cancer Vaccine Extends Life for Those With Brain Cancer     11/24/2015
Celsion (CLSN) Updates Clinical Trial Data and Slashes 20% of Workforce     9/9/2015
NW Bio (NWBO) Temporarily Halts Patient Screening for DCVax-L Brain Cancer Study     8/24/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
EXCLUSIVE: Experimental Cancer Drug From Oncoceutics Could Be Fast-Tracked, Says Exec     3/6/2015
EXCLUSIVE: Science "Finally Catching Up" With GBM Tumors, Says DelMar Pharmaceuticals CEO     2/27/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
AbbVie (ABBV) Touts Early Phase 1 Success With Brain Cancer Drug     6/2/2014
AngioChem's ANG1005 Received Fast Track And Orphan Drug Designation From FDA For The Treatment Of Glioblastoma Multiforme     5/30/2014
ImmunoCellular Therapeutics, Ltd (IMUC) Killed As Brain Cancer Drug Fails Key Phase 2 Study; Stock Down -59.56% At 10:12AM ET On Thursday     12/13/2013
EMD Serono Reports Disappointing Results for Cancer Drug Test     2/25/2013

News from Around the Web
New Approach To Gene Therapy May Shrink Brain Tumors, Prevent Their Spread, Massachusetts General Hospital Neuroscience Center Study     9/26/2008
Brain Cancer Vaccine's Immune Response Key to Outcomes, Cedars-Sinai Study     7/16/2008
University of Alabama at Birmingham-Developed Glioma Drug Shows Promise in Phase 1 Trial     11/12/2007
Mayo Clinic Tests Novel Vaccine to Treat Aggressive Brain Tumors     10/24/2007
Genentech, Inc. (DNA)'s Avastin Seen As Helpful Against Deadly Brain Tumor     10/19/2007
University of California, San Francisco (UCSF) Brain Tumor Vaccine Trial Shows Promising Results     4/16/2007
Starve Brain Tumors Of Blood Shows Positive Results     1/22/2007
Cancer Immunoresistance Linked To Loss Of Tumor Suppressor Gene     12/11/2006
Brain Cancer Vaccine Made From Patients' Tumours     11/17/2006
Alkermes (ALKS) More Than A Drug Delivery Company     7/17/2006
Ark To File For Exceptional Approval Of Cerepro Gene Therapy     1/17/2005
Ark Therapeutics Raises £55M, Ends IPO Drought In London     3/10/2004

Press Releases
EnGeneIC Pty Ltd Doses First Patient In U.S. Phase 1 Clinical Study Of Targeted EDV Nanocells In Recurrent Glioblastoma Multiforme     3/21/2017
ImmunoCellular Therapeutics (IMUC) Provides Update On ICT-107 Phase III Glioblastoma Trial And Announces Advances In Stem-To-T-Cell Research Program     3/6/2017
EnGeneIC Pty Ltd Receives FDA Orphan Drug Designation For Targeted EDV Nanocells To Treat Glioblastoma Multiforme     3/2/2017
Tocagen Receives Breakthrough Therapy Designation From FDA For Toca 511 & Toca FC In Recurrent High Grade Glioma     2/23/2017
Berg Initiates Phase I/II Monotherapy Trial Of BPM 31510-IV In Patients With Glioblastoma Multiforme (GBM)     2/15/2017
SAVSU Provides Performance Update On Evo Cold Chain 2.0 System In ImmunoCellular Therapeutics (IMUC) Phase lll Glioblastoma Cell Therapy Clinical Trial     2/14/2017
DelMar Pharma Announces Dosing Of The First Patient In Phase Two Clinical Trial Of VAL-083 For MGMT-Unmethylated Recurrent Glioblastoma Multiforme (GBM)     2/13/2017
TRACON Pharma (TCON) Announces Top-Line Results From NCI-Sponsored Phase 2 Trial Of TRC105 In Recurrent Glioblastoma     2/10/2017
Diffusion Pharma’ TSC Phase I/II Glioblastoma Multiforme Clinical Trial Results Published In February 2017 Edition Of Journal Of Neurosurgery     2/8/2017
GW Pharma (GWPH) Achieves Positive Results In Phase II Proof Of Concept Study In Glioma     2/7/2017
DelMar Pharma Release: Company And MD Anderson Cancer Center Initiate New Phase Two Clinical Trial Of VAL-083 For MGMT-Unmethylated Recurrent Glioblastoma Multiforme (GBM)     1/25/2017
Agenus (AGEN) Release: Company Announces Collaboration With The NCI To Evaluate The Combination Of Pembrolizumab (Keytruda, Merck & Co. (MRK)) With Prophage (Agenus Inc.) Autologous Vaccine     1/17/2017
MRI Interventions (MRIC)’ ClearPoint Neuro Navigation System To Be Utilized In Medicenna’ Phase 2 MDNA55 Clinical Trial For The Treatment Of Recurrent Glioblastoma     12/20/2016
ImmunoCellular Therapeutics, Ltd (IMUC) Reports Updated Immune Monitoring Data From ICT-107 Phase 2 Trial In Newly Diagnosed Glioblastoma At The Society For Neuro-Oncology Annual Meeting 2016     11/21/2016
Cortice Biosciences Announces Presentation Of Results From A Phase I/II Clinical Trial Evaluating TPI 287 For Treatment Of Recurrent Glioblastoma At The 21st Annual Scientific Meeting Of The Society Of Neuro-Oncology     11/21/2016